ADAM17 and hypertensive disorder: In addition, using Neuro2A cells (neuroblastoma cell line) and a DOCA-salt model of hypertension, the antioxidant therapy preserved ACE2 compensatory role by breaking the feedforward cycle between oxidative stress and ADAM17 especially due to the oxidative stress decreasing.